SHRX — Sharp Therapeutics News Story

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapNeutral

Brief: Sharp Therapeutics Presents New Preclinical Data Supporting Novel Small-Molecule Therapeutic Approach For Niemann-Pick Disease Type C

28/05/2026 21:01

BRIEF-Sharp Therapeutics Presents New Preclinical Data Supporting Novel Small-Molecule Therapeutic Approach For Niemann-Pick Disease Type C

May 28 (Reuters) - Sharp Therapeutics Corp SHRX.V:

SHARP THERAPEUTICS PRESENTS NEW PRECLINICAL DATA SUPPORTING NOVEL SMALL-MOLECULE THERAPEUTIC APPROACH FOR NIEMANN-PICK DISEASE TYPE C

Source text: ID:nGNXbjBRK

Further company coverage: SHRX.V